|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
5778745 |
| 003 |
ICU |
| 005 |
20060911121000.0 |
| 008 |
041112s2005 maua b 001 0 eng |
| 010 |
|
|
|a 2004027018
|
| 020 |
|
|
|a 9781405130059 (alk. paper)
|
| 020 |
|
|
|a 1405130059 (alk. paper)
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d UtOrBLW
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC848.H43
|b V58 2005
|
| 060 |
1 |
0 |
|a WC 536
|b V81281 2005
|
| 082 |
0 |
0 |
|a 616.3/623
|2 22
|
| 245 |
0 |
0 |
|a Viral hepatitis /
|c edited by Howard Thomas, Stanley Lemon, Arie Zuckerman.
|
| 250 |
|
|
|a 3rd ed.
|
| 260 |
|
|
|a Malden, Mass. :
|b Blackwell Pub.,
|c c2005.
|
| 300 |
|
|
|a xiii, 876 p. :
|b ill. ;
|c 28 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t Liver stem cells in persistent viral infection, liver regeneration and cancer /
|r Stuart Forbes and Malcolm Alison --
|g 2.
|t Hepatic immunology /
|r Cliona O'Farrelly, Robert H. Pierce and Nicholas Crispe --
|g 3.
|t Clinical features of hepatitis /
|r Arie Regev and Eugene R. Schiff --
|g 4.
|t Diagnostic approach to viral hepatitis /
|r Julie C. Servoss, Lawrence S. Friedman and Jules L. Dienstag --
|g 5.
|t Evolution of hepatitis viruses /
|r Peter Simmonds --
|g 6.
|t Structure and molecular virology /
|r Stanley M. Lemon and Annette Martin --
|g 7.
|t Epidemiology /
|r Mike G. Catton and Stephen A. Locarnini --
|g 8.
|t Natural history and experimental models /
|r Robert H. Purcell and Suzanne U. Emerson --
|g 9.
|t Prevention /
|r Beth P. Bell --
|g 10.
|t Structure and molecular virology /
|r Michael Kann and Wolfram H. Gerlich --
|g 11.
|t Epidemiology /
|r Daniel Lavanchy --
|g 12.
|t Avihepadnaviridae /
|r Allison R. Jilbert and Stephen A. Locarnini --
|g 13.
|t Woodchuck hepatitis virus /
|r Michael Roggendorf and Michael Lu --
|g 14.
|t Hepatitis B surface antigen (HBsAg) variants /
|r William F. Carman, Mohammad Jazayeri, Ashraf Basuni, Howard C. Thomas and Peter Karayiannis --
|g 15.
|t Molecular variations in the core promoter, precore and core regions of hepatitis B virus, and their clinical significance /
|r Peter Karayiannis, William F. Carman and Howard C. Thomas --
|g 16.
|t Natural history of chronic hepatitis B and hepatocellular carcinoma /
|r Massimo Colombo and Pietro Lampertico --
|g 17.
|t Hepatocellular carcinoma : molecular aspects in hepatitis B /
|r Marie Annick Buendia, Patricia Paterlini-Brechot, Pierre Tiollais and Christian Brechot --
|g 18.
|t Murine models and hepatitis B virus infection /
|r David R. Milich --
|g 19.
|t Pathogenesis of chronic hepatitis B /
|r Mark R. Thursz and Howard C. Thomas --
|g 20.
|t Treatment of chronic hepatitis B /
|r Patrick Marcellin, Tarik Asselah and Nathalie Boyer --
|g 21.
|t Management of drug-resistant mutants /
|r Yun-Fan Liaw --
|g 22.
|t Liver transplantation in the management of chronic viral hepatitis /
|r Marina Berenguer and Teresa L. Wright --
|g 23.
|t Prevention /
|r Jane N. Zuckerman --
|g 24.
|t Structure and molecular virology /
|r Michael J. McGarvey and Michael Houghton --
|g 25.
|t Epidemiology /
|r Josep Quer and Juan I. Esteban Mur --
|g 26.
|t The immune response to hepatitis C virus in acute and chronic infection /
|r Khadija Iken and Margaret J. Koziel --
|g 27.
|t Natural history and experimental models /
|r Patrizia Farci, Jens Bukh and Robert H. Purcell --
|g 28.
|t Autoimmune disorders /
|r Elmar Jaeckel and Michael P. Manns --
|g 29.
|t Central nervous system complications /
|r Daniel M. Forton, Simon D. Taylor-Robinson, I. Jane Cox and Howard C. Thomas --
|g 30.
|t In vitro replication models /
|r Ralf Bartenschlager and Sandra Sparacio --
|g 31.
|t Progression of fibrosis /
|r Thierry Poynard, Vlad Ratziu, Yves Benhamou, Dominique Thabut and Joseph Moussalli --
|g 32.
|t The natural history of hepatitis C and hepatocellular carcinoma /
|r Edward Tabor --
|g 33.
|t Treatment of chronic hepatitis C /
|r Jenny Heathcote and Janice Main --
|g 34.
|t New drugs for the management of hepatitis C /
|r John G. McHutchison, Jennifer M. King and Amany Zekry --
|g 35.
|t Prevention /
|r Sergio Abrignani, Grazia Galli and Michael Houghton --
|g 36.
|t Structure and molecular virology /
|r Michael M. C. Lai --
|g 37.
|t Epidemiology and natural history /
|r Floriano Rosina and Mario Rizzetto --
|g 38.
|t Treatment /
|r Grazia Anna Niro, Floriano Rosina and Mario Rizzetto --
|g 39.
|t Structure and molecular virology /
|r David A. Anderson and R. Holland Cheng --
|g 40.
|t Hepatitis E as a zoonotic disease /
|r Xiang-Jin Meng --
|g 41.
|t Epidemiology, clinical and pathologic features, diagnosis, and experimental models /
|r Kris Krawczynski, Rakesh Aggarwal and Saleem Kamili --
|g 42.
|t Prevention /
|r Robert H. Purcell and Suzanne U. Emerson --
|g 43.
|t Aetiology of fulminant hepatitis /
|r Kittichai Promrat and Jack R. Wands --
|g 44.
|t Treatment of fulminant hepatitis /
|r Kinan Rifai, Hans L. Tillmann and Michael P. Manns --
|g 45.
|t Hepatitis and haemophilia /
|r Christine A. Lee --
|g 46.
|t Occupational aspects of hepatitis /
|r William L. Irving and Kit Harling --
|g 47.
|t Neonatal and paediatric infection /
|r Deirdre Kelly and Elizabeth Boxall --
|g 48.
|t Management of hepatocellular cancer /
|r Helen L. Reeves and Jordi Bruix --
|g 49.
|t Application of molecular biology to the diagnosis of viral hepatitis /
|r Jean-Michel Pawlotsky --
|g 50.
|t Hepatitis in HIV-infected persons /
|r Janice Main and Brendan McCarron --
|g 51.
|t Treatment of extrahepatic diseases caused by hepatitis B and hepatitis C viruses /
|r Philippe Merle and Christian Trepo --
|g 52.
|t The histologist's role in the diagnosis and management of chronic hepatitis B and C /
|r Robert Goldin and Geoffrey M. Dusheiko --
|g 53.
|t Disinfection and sterilization /
|r Martin S. Favero and Walter W. Bond --
|g 54.
|t Mechanisms of interferon resistance /
|r Darius Moradpour, Markus H. Heim and Hubert E. Blum --
|g 55.
|t New in vitro testing systems for hepatitis B and C viruses /
|r David Durantel, Olivier Hantz, Christian Trepo and Fabien Zoulim --
|g 56.
|t New vaccine technologies and the control of viral hepatitis /
|r Colin R. Howard --
|g 57.
|t Safety of hepatitis B vaccines /
|r Arie J. Zuckerman --
|g 58.
|t Before and since the discovery of Australia antigen : a chronological review of viral hepatitis /
|r Philip P. Mortimer and Arie J. Zuckerman.
|
| 650 |
|
0 |
|a Hepatitis, Viral.
|0 http://id.loc.gov/authorities/subjects/sh85060291
|
| 650 |
1 |
2 |
|a Hepatitis, Viral, Human.
|
| 650 |
2 |
2 |
|a Hepatitis Viruses.
|
| 650 |
|
7 |
|a Hepatitis, Viral.
|2 fast
|0 http://id.worldcat.org/fast/fst00955226
|
| 700 |
1 |
|
|a Thomas, H. C.
|q (Howard C.)
|0 http://id.loc.gov/authorities/names/n81152513
|1 http://viaf.org/viaf/7965193
|
| 700 |
1 |
|
|a Lemon, Stanley M.
|0 http://id.loc.gov/authorities/names/n89122640
|1 http://viaf.org/viaf/203979906
|
| 700 |
1 |
|
|a Zuckerman, Arie J.
|0 http://id.loc.gov/authorities/names/n85074901
|1 http://viaf.org/viaf/5030899
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)57001855
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 783685ae-9d37-50ed-a695-cf61d7cbedfa
|s d6fd972e-5bad-5fa8-abb1-efe820008ca2
|
| 928 |
|
|
|t Library of Congress classification
|a RC848.H43 V58 2005
|l JCL
|c JCL-Sci
|i 5041180
|
| 927 |
|
|
|t Library of Congress classification
|a RC848.H43 V58 2005
|l JCL
|c JCL-Sci
|e CRERAR
|b 71028165
|i 7931557
|
